69.07

0.10% 0.07

After Hours: 69.07

Prestige Consumer Healthcare Inc (PBH)

Overview News Price History Option Chain Financials Discussions Forecast

Prestige Consumer Healthcare Inc stock is traded at $69.07, with a volume of 410.44K. It is up +0.10% in the last 24 hours and up +3.04% over the past month. Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Previous Close:

$69.00

Open:

$69.13

24h Volume:

410.44K

Relative Volume:

0.99

Market Cap:

$3.27B

Revenue:

$1.11B

Net Income/Loss:

$200.84M

P/E Ratio:

17.13

EPS:

4.0314

Net Cash Flow:

$255.45M

1W Performance:

-0.45%

1M Performance:

+3.04%

6M Performance:

+3.48%

1Y Performance:

-18.00%

1-Day Range:

$67.46

$69.51

1-Week Range:

$66.54

$70.64

52-Week Range:

$57.25

$90.04

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Name

Prestige Consumer Healthcare Inc

Sector

Healthcare (1113)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

(914) 524-6800

Address

660 WHITE PLAINS RD., TARRYTOWN, NY

Employee

600

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PBH's Discussions on Twitter

Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBH Prestige Consumer Healthcare Inc	69.07	3.26B	1.11B	200.84M	255.45M	4.0314
TAK Takeda Pharmaceutical Co Adr	18.22	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	125.98	53.16B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.48	47.25B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	32.88	37.59B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	490.21	21.85B	3.13B	1.27B	1.12B	26.39

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Upgrade	Sidoti	Neutral → Buy
Dec-09-24	Downgrade	Sidoti	Buy → Neutral
Jun-21-24	Upgrade	DA Davidson	Neutral → Buy
Nov-17-22	Initiated	Canaccord Genuity	Buy
May-10-22	Upgrade	Jefferies	Hold → Buy
May-09-22	Upgrade	Oppenheimer	Perform → Outperform
Aug-07-20	Downgrade	DA Davidson	Buy → Neutral
Jun-29-20	Upgrade	Sidoti	Neutral → Buy
Apr-14-20	Downgrade	Jefferies	Buy → Hold
Apr-07-20	Resumed	Sidoti	Neutral
Mar-26-20	Upgrade	Jefferies	Hold → Buy
Mar-24-20	Initiated	Oppenheimer	Perform
Mar-19-20	Upgrade	DA Davidson	Neutral → Buy
Jan-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-04-17	Upgrade	William Blair	Mkt Perform → Outperform
Jun-02-17	Upgrade	Jefferies	Underperform → Hold
May-22-17	Upgrade	Raymond James	Mkt Perform → Outperform
Dec-27-16	Reiterated	B. Riley & Co.	Buy
Nov-17-16	Initiated	Gabelli & Co	Buy
Aug-12-16	Upgrade	Sidoti	Neutral → Buy
Mar-08-16	Initiated	KeyBanc Capital Mkts	Overweight
Feb-05-16	Initiated	Piper Jaffray	Overweight
Nov-30-15	Downgrade	Jefferies	Hold → Underperform
Apr-28-14	Reiterated	B. Riley & Co.	Buy
Apr-28-14	Reiterated	Oppenheimer	Outperform
Jul-09-13	Initiated	B. Riley & Co.	Buy

View All

Prestige Consumer Healthcare Inc Stock (PBH) Latest News

04:37 AM

Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

04:37 AM

Mar 03, 2026

PBH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 03, 2026

Mar 02, 2026